Patent · US Active

Polypeptides with altered binding to neonatal Fc receptor (FcRn) and methods of use

US11434276B2 · kind B2 · utility

0Cited by
18References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 11, 2021
Grant dateSep 6, 2022
Priority date
Expiry dateMay 11, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided are compositions for increasing the half-life of a polypeptide or polypeptides in a canine and methods of their use. The compositions involve variant canine IgG Fc regions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.